Can intranasal drug use reduce HCV infection among injecting drug users?
Saved in:
Des Jarlais, D.C., ET AL., Can intranasal drug use reduce HCV infection among injecting drug users?. Drug and Alcohol Dependence, Vol. 119, no. 3 (2011), p. 201-206.
Ref.
183549
Location:
SIIS R.854 Archivo
Palabras clave:
Datos estadísticos, Drogodependencias, Evaluación de servicios, Hepatitis, Heroína, Inhalantes, Patrones de consumo, Programas de desintoxicación, Vía intravenosa, EE.UU.
Datos estadísticos, Drogodependencias, Evaluación de servicios, Hepatitis, Heroína, Inhalantes, Patrones de consumo, Programas de desintoxicación, Vía intravenosa, EE.UU.
Similar Items: Can intranasal drug use reduce HCV infection among injecting drug users?
- Transitions from injecting to non-injecting drug use: petential protection against HCV infection
- SYRINGE EXCHANGE, INJECTING AND INTRANASAL DRUG USE
- GLOBAL ESTIMATES OF PREVALENCE OF HCV INFECTION AMONG INJECTING DRUG USERS
- IMPAIRED CYTOKINE PRODUCTION AND SUPPRESSED LYMPHOCYTE PROLIFERATION ACTIVITY IN HCV INFECTED COCAINE AND HEROIN (SPEEDBALL) USERS
- THE TRANSITION FROM INJECTION TO NON-INJECTION DRUG USE: LONG-TERM OUTCOMES AMONG HEROIN AND COCAINE USERS IN NEW YORK CITY
- Measuring risk of HIV and HCV among injecting drug users in the Russian Federation